Buprenorphine for Opioid Use Disorder—An Essential Medical Treatment
This Clinical Insights describes the process for initiating buprenorphine treatment for patients with opioid use disorder.
This Clinical Insights describes the process for initiating buprenorphine treatment for patients with opioid use disorder.
We are pleased to announce that JAMA Neurology is again offering a 1-year editorial fellowship position for a qualified individual. The fellow will receive hands-on…
This quasi-experimental study evaluates the association between the distribution of rapid diagnostic tests for malaria and the management of febrile illness and mortality among children…
A man in his 70s presented with 2 enlarging, painless nodular lesions on the forehead and right cheek. Histopathological examination showed extensive dermal collection of…
This JAMA Oncology Patient Page describes cardio-oncology, a relatively new area in medicine that focuses on taking care of the heart while going through cancer…
The Priming Immunity at the Beginning of Life (PRIMAL) randomized clinical trial investigates if preterm infant exposure to multistrain Bifidobacteria and Lactobacillus probiotics reduces the…
The ER fluticasone propionate intra-articular injection significantly reduced pain compared with control for up to 14 weeks.
On 8 July a Russian missile strike heavily damaged Ukraine’s main children’s hospital. The damage to the city, and the country, was severe, reports Nataliia…
Medicare Advantage rebates fund extra benefits but increase costs for traditional Medicare enrollees. Could other methods of providing extra benefits improve beneficiary outcomes and Medicare’s…
An 18-year-old man with type 1 diabetes mellitus who had been admitted with diabetic ketoacidosis had unexpected elevations in aminotransferase levels. CT of the abdomen…
Pain is your body’s way of telling you it needs your attention. Talk with a healthcare provider to get to the cause. But in the…